• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Latest News

Journal Digest: April 23
Journal Digest: April 23

April 23rd 2025

Daily Derm Times: April 22, 2025
Daily Derm Times: April 22, 2025

April 23rd 2025

Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes
Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes

April 22nd 2025

Using Real-World AD Cases to Pick the Right Therapy for Each Patient
Using Real-World AD Cases to Pick the Right Therapy for Each Patient

April 22nd 2025

Register Now for Revolutionizing Atopic Dermatitis
Minimize Complications With Advanced Laser Techniques
Introducing Dermatology Times' 2025 Editor in Chief
Pediatric vs Adult Atopic Dermatitis Care
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Advancing AD Treatment: Expert-Led Case Discussions
Breaking Down New Treatment Options in Pediatric Atopic Dermatitis
Stay Informed!
Don't miss the latest in dermatology news

Conference Coverage

View All
Expert Insights From AAD 2025
Expert Insights From AAD 2025

April 17th 2025

One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research
One-Stop Shop: RAD Offers Comprehensive Insights Into AD Diagnosis, Treatment, and Research

April 16th 2025

Nonsteroidal Tapinarof Cream Provides Long-Lasting AD Relief
Nonsteroidal Tapinarof Cream Provides Long-Lasting AD Relief

April 16th 2025

Icotrokinra Demonstrates Efficacy in Adolescents and Adults With Moderate to Severe Psoriasis in ICONIC-LEAD Phase 3 Study
Icotrokinra Demonstrates Efficacy in Adolescents and Adults With Moderate to Severe Psoriasis in ICONIC-LEAD Phase 3 Study

April 10th 2025

Latest Videos

All News

© 2025 MJH Life Sciences

All rights reserved.